L J Tiefenbrunn, T A Riemenschneider. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AnimalsCardiomyopathies/physiopathologyCatheterizationDiagnosis, DifferentialDisease Models, AnimalDobutamine/therapeutic useEchocardiographyHeart Failure/physiopathologyHumansHyperventilation/diagnosisInfant, NewbornMuscle DevelopmentMuscle, Smooth, Vascular/growth & developmentPersistent Fetal Circulation Syndrome/diagnosisPersistent Fetal Circulation Syndrome/drug therapyPersistent Fetal Circulation Syndrome/etiologyPersistent Fetal Circulation Syndrome/physiopathologyPersistent Fetal Circulation Syndrome/therapyPositive-Pressure RespirationPulmonary CirculationTolazoline/adverse effectsTolazoline/therapeutic use
Substances： See more » DobutamineTolazoline
Year: 1986 PMID： 3513499 DOI： 10.1016/0002-8703(86)90065-7
Source DB: PubMed Journal: Am Heart J ISSN： 0002-8703 Impact factor: 4.749